Latest news
Weekly Commentary: Bessent's Gambit - Seeking AlphaSeeking Alpha · Sat, 08 Aug 2026 08:30:14 GMTStoke Therapeutics, Inc. 2026 Q2 - Results - Earnings Call Presentation (NASDAQ:STOK) 2026-08-07 - Seeking AlphaSeeking Alpha · Sat, 08 Aug 2026 00:20:19 GMTCalamos International Growth Fund Q2 2026 Commentary - Seeking AlphaSeeking Alpha · Thu, 06 Aug 2026 13:13:00 GMTDiamond Hill Small Cap Fund Q2 2026 Portfolio Activity - Seeking AlphaSeeking Alpha · Wed, 05 Aug 2026 18:05:00 GMTStoke: 'Buy' Zorevunersen NDA SCN1A DS And STK-002 Advancement (NASDAQ:STOK) - Seeking AlphaSeeking Alpha · Wed, 05 Aug 2026 17:50:02 GMTabrdn Focused U.S. Small Cap Active ETF Q2 2026 Commentary - Seeking AlphaSeeking Alpha · Wed, 05 Aug 2026 16:50:00 GMTBlossomHill Therapeutics Aims For $125 Million IPO On Cancer Treatment Pipeline Promise - Seeking AlphaSeeking Alpha · Wed, 05 Aug 2026 14:42:32 GMTBicycle: 'Hold' On Zelenectide Deprioritization And Shift To EphA2+ Tumor Targeting - Seeking AlphaSeeking Alpha · Tue, 04 Aug 2026 14:40:25 GMT